Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
Current Urology Reports
|
November 12, 2002
Advances in drug delivery: improved bioavailability and drug effect
Roger R Dmochowski, David R Staskin
Current Urology Reports
|
November 16, 2004
Effect of trospium chloride on somnolence and sleepiness in patients with overactive bladder
David R Staskin, Mark D Harnett
BJU International
|
May 12, 2006
Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence
David R Staskin, Alexis E Te
The Journal of Urology
|
October 23, 2009
Re: Benign prostatic obstruction and Parkinson's disease--should transurethral resection of the prostate be avoided? B. Roth, U. E. Studer, C. J. Fowler and T. M. Kessler. J Urol 2009; 181: 2209-2213
David R Staskin, Michael B Siroky
European Urology
|
October 31, 2008
Re: Giacomo Novara, Antonio Galfano, Silvia Secco, et al. A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol 2008;54:740-64
David R Staskin, Michael G Oefelein
The American Journal of Medicine
|
February 18, 2006
Using anticholinergics to treat overactive bladder: the issue of treatment tolerability
David R Staskin, Scott A MacDiarmid
The American Journal of Medicine
|
February 18, 2006
Pharmacologic management of overactive bladder: practical options for the primary care physician
David R Staskin, Scott A MacDiarmid
Open Access Journal of Urology
|
November 8, 2013
Development of oxybutynin chloride topical gel for overactive bladder
Vincent R Lucente, David R Staskin, Elise De
Reviews in Urology
|
September 3, 2010
Surgical options for drug-refractory overactive bladder patients
Jonathan S Starkman, Christopher P Smith, David R Staskin
Current Urology Reports
|
November 19, 2003
Trospium chloride: a quaternary amine with unique pharmacologic properties
Raymond W Pak, Steven P Petrou, David R Staskin
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
Current Urology Reports
|
November 12, 2002
Advances in drug delivery: improved bioavailability and drug effect
Roger R Dmochowski, David R Staskin
Current Urology Reports
|
November 16, 2004
Effect of trospium chloride on somnolence and sleepiness in patients with overactive bladder
David R Staskin, Mark D Harnett
BJU International
|
May 12, 2006
Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence
David R Staskin, Alexis E Te
The Journal of Urology
|
October 23, 2009
Re: Benign prostatic obstruction and Parkinson's disease--should transurethral resection of the prostate be avoided? B. Roth, U. E. Studer, C. J. Fowler and T. M. Kessler. J Urol 2009; 181: 2209-2213
David R Staskin, Michael B Siroky
European Urology
|
October 31, 2008
Re: Giacomo Novara, Antonio Galfano, Silvia Secco, et al. A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol 2008;54:740-64
David R Staskin, Michael G Oefelein
The American Journal of Medicine
|
February 18, 2006
Using anticholinergics to treat overactive bladder: the issue of treatment tolerability
David R Staskin, Scott A MacDiarmid
The American Journal of Medicine
|
February 18, 2006
Pharmacologic management of overactive bladder: practical options for the primary care physician
David R Staskin, Scott A MacDiarmid
Open Access Journal of Urology
|
November 8, 2013
Development of oxybutynin chloride topical gel for overactive bladder
Vincent R Lucente, David R Staskin, Elise De
Reviews in Urology
|
September 3, 2010
Surgical options for drug-refractory overactive bladder patients
Jonathan S Starkman, Christopher P Smith, David R Staskin
Current Urology Reports
|
November 19, 2003
Trospium chloride: a quaternary amine with unique pharmacologic properties
Raymond W Pak, Steven P Petrou, David R Staskin
Page
of 6